Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setoyama, M.
Right arrow Articles by Kamada, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setoyama, M.
Right arrow Articles by Kamada, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 92 No. 4 (August 15), 1998: pp. 1454-1455

CORRESPONDENCE

A Unique Translocation of the TEL Gene in a Case of Acute Myelogenous Leukemia With inv(12)(p13q15)

    LETTER

To the Editor:

Chromosome band 12p13 is known as a recurring site for cytogenetic alteration in a variety of hematological malignancies such as acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), and myelodysplastic syndrome (MDS).1 Recently, the TEL gene has been shown to be involved in hematological malignancies with 12p13 aberration, most of which exhibit reciprocal translocation between 12p13 and various partner loci, including 3q26, 5q33, 9q34, 21q22, and 22q11. By 12p13 translocation, the TEL gene is disrupted and fused to its partner genes such as PDGFR-beta ,2 ABL,3 and AML-1.4 On the other hand, invesion 12 at p13 is a rare abnormality and only 9 cases (1 AML and 8 MDS) were reported previously.5-8 Whether the TEL gene is involved in this aberration has not been determined. We describe here an additional case of AML with inv(12)(p13q15) in which the rearrangement of the TEL gene was demonstrated by fluorescence in situ hybridization (FISH).

A 59-year-old woman was referred to our hospital because of marked leukocytosis associated with pharyngitis in April 1995. Until then, she had no history of abnormal hematological data in a routine check-up. On admission, hepatosplenomegaly was pointed out and her white blood cell count was 127 × 109/L with 90% of blasts, which were positive for myeloperoxidase and ASD-chrolo-acetate. The morphology of the blasts was compatible with FAB-M2. Surface markers were positive for CD33 and weakly positive for CD7, CD13, and HLA-DR. Bone marrow aspiration proved dry tap, but a biopsy specimen showed hypercellular marrow with diffuse and severe myelofibrosis. The karyotype analysis of peripheral blasts showed a main clone with 48 XX, add(6)(q27), +8, inv(12)(p13q15), add(15)(q25), +add(15)(q25) (Fig 1). The patient was diagnosed as AML-M2 and then received two courses of induction therapy with behenoyl arabinosylcytosine, daunorubicin, 6-mercaptopurine, and prednisone, but could not achieve remission. The further salvage therapy with cytosine arabinoside, etoposide, predonisone, and mitoxantrone also resulted in treatment failure. She died of multiple organ failure in August 1995, and autopsy specimens disclosed massive infiltration of leukemia cells in spleen, liver, lungs, brain, kidneys, adrenal glands, stomach, colon, skin, pharynx, tonsil, and systemic lymph nodes.


View larger version (19K):
[in this window]
[in a new window]
 
Fig 1. G-banded karyotypes of a leukemia cell. Structurally abnormal or additional chromosomes are shown by arrows.

Southern blot hybridization was performed on blast cells using two kinds of TEL cDNA probes corresponding to exon 2 and 3 of the gene,2,9 respectively. After EcoRI and HindIII digestion, the patient sample did not show any rearranged bands (data not shown). Next, FISH analysis was performed with a yeast artificial chromosome (YAC 964c10).1 Signal for this probe was split and found on 12q and 15q terminal, suggesting the presence of t(12;15)(p13;q25), which could not be detected using a conventional technique (Fig 2). However, no signal remained on 12p. Further analysis by FISH using cosmid probes 2G8 and 148B69 suggested that the 5' portion of the TEL gene would be translocated to 15q and the 3' portion to 12q (data not shown). Then, two novel fusion partners of the TEL gene are expected in the present case.


View larger version (102K):
[in this window]
[in a new window]
 
Fig 2. The mapping of YAC 964c10 (red) and cosmid D12Z3 (green) to a leukemia cell. The latter is a centromere probe for chromosome 12. The normal and rearranged chromosome 12 are indicated by an arrowhead and a large arrow, respectively. der(15) chromosome is identified with a short arrow. YAC 964c10 hybridized to the normal chromosome 12 and der(12) as well as to the der(15) chromosome. Signals on the der(12) are smaller than those on the other chromosomes

Misao Setoyama
Arinobu Tojo
Fumitaka Nagamura
Shigetaka Asano
Department of Hematology/Oncology
The Institute of Medical Science
University of Tokyo
Tokyo, Japan

Minenori Ishimae
Mariko Eguchi
Nanao Kamada
Department of Cancer Cytogenetics
Division of Molecular Biology
Research Institute for Radiation Biology and Medicine
Hiroshima University
Hiroshima, Japan

  

    REFERENCES

1. Kobayashi H, Montgomery KT, Bohlander SK, Adra CN, Lim BL, Kucherlapati RL, Donis-Keller H, Holt MS, Le Beau MM, Rowley JD: Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 84:3473, 1994[Abstract/Free Full Text]

2. Golub TR, Baker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor b to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994[Medline] [Order article via Infotrieve]

3. Papadonpoulos P, Ridge SA, Boucher CA, Stocking C, Wiedermann LM: The novel activation of ABL by fusion to est-related gene, TEL. Cancer Res 55:34, 1995[Abstract/Free Full Text]

4. Goulb TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995[Abstract/Free Full Text]

5. Larripa I, Mecucci C, Testoni N, Bosly A, Doyen C, Tytgat H, van den Berghe H: Inversion of chromosome 12 in human malignancies. Cancer Genet Cytogenet 28:113, 1987[Medline] [Order article via Infotrieve]

6. Huret JL, Brizard A, Briault S, Dreyfus B, Giraud C, Tanzer J: Two additional cases of inv(12) in human malignancies. Cancer Genet Cytogenet 32:309, 1988[Medline] [Order article via Infotrieve]

7. Hasegawa Y, Sakai N, Toyama M, Ninomiya H, Abe T: Chronic myelomonocytic leukemia transformed from refractory anemia with ringed sideroblasts with a rare abnormal chromosome, inv(12). Jpn J Clin Hematol 31:75, 1990

8. Huret JL, Brizard A, Guilhot F, Couet D, Schoenwald M, Savage JRK, Tanzer J: INV(12)(p13q11) and dicentric chromosomes in a secondary leukemia with basophilia. Hametologica 75:473, 1990

9. Mathijs B, Pieter P, Caiying G, Jeroen A, Peter M: Genomic organization of TEL: The human ETS-variant gene 6. Genome Res 6:404, 1996[Abstract/Free Full Text]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. Eguchi, M. Eguchi-Ishimae, A. Tojo, K. Morishita, K. Suzuki, Y. Sato, S. Kudoh, K. Tanaka, M. Setoyama, F. Nagamura, et al.
Fusion of ETV6 to Neurotrophin-3 Receptor TRKC in Acute Myeloid Leukemia With t(12;15)(p13;q25)
Blood, February 15, 1999; 93(4): 1355 - 1363.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setoyama, M.
Right arrow Articles by Kamada, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setoyama, M.
Right arrow Articles by Kamada, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020